Elanco Animal Health (ELAN) Other financing activities (2017 - 2026)

Elanco Animal Health has disclosed Other financing activities across 10 years of filings, most recently posting -$15.0 million for Q1 2026.

• In Q1 2026, Other financing activities fell 114.29% year-over-year to -$15.0 million; the TTM figure through Jun 2026 stood at -$11.0 million (down 37.5% YoY), while the FY2025 annual figure was -$2.0 million, up 88.24% from the prior year.
• Other financing activities came in at -$15.0 million for Q1 2026 at Elanco Animal Health, up from -$17.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $21.0 million in Q3 2025 to a low of -$17.0 million in Q4 2025.
• Average Other financing activities over 5 years is -$4.5 million, with a median of -$6.5 million recorded in 2022.
• Year-over-year, Other financing activities plunged 700.0% in 2024 and jumped 362.5% in 2025.
• Over 5 years, Other financing activities stood at $1.0 million in 2022, then plunged by 200.0% to -$1.0 million in 2023, then surged by 700.0% to $6.0 million in 2024, then sank by 383.33% to -$17.0 million in 2025, then advanced by 11.76% to -$15.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were -$15.0 million in Q1 2026, -$17.0 million in Q4 2025, and $21.0 million in Q3 2025.